article thumbnail

Colin Bower Joins VivoSense as Chief Executive Officer

Digital Health Global

Colin’s track record with global biopharma and biotech partners is extensive and admirable,” added Chris Garabedian, a VivoSense Board Member. “He He has consistently worked to improve the speed, safety, and cost-effectiveness of clinical trials through the adoption of new technological solutions.

BioTech 88
article thumbnail

Koneksa Announces Expanded Partnership with SSI Strategy to Scale the Adoption of Digital Biomarkers in Clinical Trials

Digital Health Global

About Koneksa Koneksa is a healthcare technology company pioneering evidence-based digital biomarkers to accelerate clinical research and guide decision-making in drug development and market strategy. Our evidence-based biomarker solutions enable efficient clinical trial designs to help innovative therapies reach patients faster.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Koneksa Announces Partnership with Beacon Biosignals for Clinical Trial in Sleep and Neurologic Disorders Using EEG Biomarkers

Digital Health Global

About Koneksa Koneksa is a healthcare technology company pioneering evidence-based digital biomarkers to accelerate clinical research and guide decision-making in drug development and market strategy. Our evidence-based biomarker solutions enable efficient clinical trial designs to help innovative therapies reach patients faster.

article thumbnail

Scotland's Pioneering Spirit: A Legacy of Medical and Healthcare Innovation

Lloyd Price

As the digital health sector continues to grow, Scotland is well-positioned to play a leading role in shaping the future of healthcare. Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.

article thumbnail

Turbine Upsizes its Series A Round to €25.5 Million and Appoints Seasoned Independent Directors to its Board

Digital Health Global

With the additional funding and board appointments, we are set to accelerate the validation of our approach by advancing multiple programs and partnerships toward the ultimate test of any biopharma technology platform – human clinical trials.” Jane Rhodes, Ph.D., Bernd Seizinger, M.D., and Europe.

BioTech 88
article thumbnail

BlackBerry Brings its EoT Vision to Healthcare to Improve Patient Outcomes

Lloyd Price

Co-chaired by Shire, the leading global biotech focused on rare diseases, one of the Global Commission's technology pilots will explore how BlackBerry's new solution might provide real-time, actionable analysis as the Commission seeks to use technology to shorten the time to diagnosis.

BioTech 56